LONG-TERM FOLLOW-UP STUDY OF ECULIZUMAB FOR PREVENTION OF THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME

被引：0
|
作者：
Menne, Jan [1 ]
Delmas, Yahsou [2 ]
Fakhouri, Fadi [3 ,4 ]
Kincaid, John F. [5 ]
Licht, Christoph [6 ,7 ]
Minetti, Enrico E. [8 ]
Mix, Chris [9 ]
Provot, Francois [10 ]
Rondeau, Eric [11 ,12 ]
Sheerin, Neil [13 ]
Wang, Jimmy [14 ]
Weekers, Laurent E. [15 ]
Greenbaum, Larry A. [16 ,17 ]
机构：
[1] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany
[2] CHU Bordeaux, Dept Nephrol, Bordeaux, France
[3] CHU Nantes, Dept Nephrol, F-44035 Nantes 01, France
[4] CHU Nantes, UMR 643, F-44035 Nantes 01, France
[5] Alex Pharmaceut Inc, Global Med Affairs, Cheshire, CT USA
[6] Hosp Sick Children, Div Nephrol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[7] Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[8] Careggi Univ Hosp, Div Nephrol, Florence, Italy
[9] Alex Pharmaceut Inc, Global Med Sci, Cheshire, CT USA
[10] CHU Lille, Dept Nephrol, F-59037 Lille, France
[11] Hop Tenon, F-75970 Paris, France
[12] Univ Paris 06, Urgences Nephrol & Transplantat Renale, Paris, France
[13] Newcastle Univ, Dept Nephrol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[14] Alex Pharmaceut Inc, Biostat, Cheshire, CT USA
[15] CHU Liege, Serv Nephrol Dialysis & Transplantat, Liege, Belgium
[16] Emory Univ, Atlanta, GA 30322 USA
[17] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SO050
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [41] Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy
    Bren, A
    Pajek, J
    Grego, K
    Buturovic, J
    Ponikvar, R
    Lindic, J
    Knap, B
    Vizjak, A
    Ferluga, D
    Kandus, A
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1889 - 1891
  • [42] Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome
    Kveˇta Bláhová
    J. Janda
    Jirˇi Kreisinger
    E. Mateˇjková
    Anna Šedivá
    Pediatric Nephrology, 2002, 17 : 400 - 403
  • [43] Long-term follow-up of Czech children with D plus hemolytic-uremic syndrome
    Bláhová, K
    Janda, J
    Kreisinger, J
    Matejková, E
    Sedivá, A
    PEDIATRIC NEPHROLOGY, 2002, 17 (06) : 400 - 403
  • [44] Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function In Adult Patients (Pts) With Atypical Hemolytic Uremic Syndrome (aHUS)
    Fakhouri, Fadi
    Hourmant, Maryvonne
    Cataland, Spero R.
    Espinosa, Mario
    Gaber, A. Osama
    Menne, Jan
    Minetti, Enrico
    Provot, Francois
    Rondeau, Eric
    Ruggenenti, Piero
    Weekers, Laurent
    Ogawa, Masayo
    Bedrosian, Camille L.
    Legendre, Christophe
    BLOOD, 2013, 122 (21)
  • [45] Eculizumab Inhibits Thrombotic Microangiopathy and Improves Renal Function in Pediatric Patients with Atypical Hemolytic Uremic Syndrome: 1-Year Update
    Greenbaum, Laurence A.
    Fila, Marc
    Ardissino, Gianluigi
    Al-Akash, Samhar I.
    Evans, Jonathan H.
    Lieberman, Kenneth
    Maringhini, Silvio
    Pape, Lars
    Rees, Lesley
    van de Kar, Nicole C. A. J.
    Vande Walle, Johan
    Ogawa, Masayo
    Bedrosian, Camille L.
    Licht, Christoph
    BLOOD, 2014, 124 (21)
  • [46] INHIBITION OF COMPLEMENT-MEDIATED THROMBOTIC MICROANGIOPATHY WITH ECULIZUMAB IMPROVES HEMATOLOGICAL AND RENAL OUTCOMES IN ADULT PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME
    Minetti, E.
    Legendre, C.
    Hourmant, M.
    Campistol, J. M.
    Espinosa, M.
    Gaber, A. O.
    Menne, J.
    Provot, F.
    Rondeau, E.
    Ruggenenti, P.
    Ogawa, M.
    Bedrosian, C. L.
    Fakhouri, F.
    HAEMATOLOGICA, 2014, 99 : 537 - 537
  • [47] Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function In Pediatric Patients (Pts) With Atypical Hemolytic Uremic Syndrome (aHUS)
    Greenbaum, Larry
    Fila, Marc
    Ardissino, Gianluigi
    Al-Akash, Samhar
    Evans, Jonathan
    Henning, Paul
    Lieberman, Kenneth
    Maringhini, Silvio
    Pape, Lars
    Rees, Lesley
    Kar, Nicole
    Vande Walle, Johan
    Ogawa, Masayo
    Bedrosian, Camille L.
    Licht, Christoph
    BLOOD, 2013, 122 (21)
  • [48] Atypical hemolytic uremic syndrome patients with progressing thrombotic microangiopathy treated with ongoing eculizumab have favorable hematologic outcomes at 2 years
    Furman, R.
    Babu, S.
    Douglas, K.
    Bedrosian, C. L. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 755 - 756
  • [49] Follow-up of four pediatric patients with atypical Hemolitic Uremic Syndrome (aHUS) receiving eculizumab
    Mastrocinque, T. H.
    Pilan, F.
    Soeiro, E.
    Liliane, M. A. M.
    Cruz, N. A.
    Nussenzveig, P.
    Sahade, C. R. A.
    Leite, B. B. C.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1879 - 1879
  • [50] Postpartum atypical hemolytic uremic syndrome: Evaluating thrombotic microangiopathy in the pregnant woman
    So, S.
    Fischer, E.
    Gangadharan Komala, M.
    Bose, B.
    OBSTETRIC MEDICINE, 2021, 14 (02) : 105 - 108
12345